Literature DB >> 27896804

Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies.

Sonja Gandhi1,2, Eric McArthur2,3, Muhammad M Mamdani3,4, Daniel G Hackam3,5, Richard S McLachlan6, Matthew A Weir1,2, Jorge G Burneo3,6, Amit X Garg1,2,3.   

Abstract

OBJECTIVE: To examine the 30-day risk of hospitalization with hyponatremia associated with carbamazepine, valproic acid (V), phenytoin (P), or topiramate (T) use compared to nonuse in the outpatient setting among older adults.
METHODS: We conducted two population-based, retrospective cohort studies in Ontario, Canada, between 2003 and 2015 using administrative health care databases of older adults. The first study compared carbamazepine users to a propensity-score matched group of antiepileptic drug nonusers, whereas the second compared V-P-T users to a propensity-score matched group of antiepileptic nonusers. The primary outcome was hospitalization with hyponatremia within 30 days of an antiepileptic prescription.
RESULTS: The baseline characteristics between matched groups were similar in both cohorts. Carbamazepine use versus nonuse was associated with a higher 30-day risk of hospitalization with hyponatremia (82/21,191 [0.39%] versus 30/63,573 [0.05%]; relative risk [RR] 8.20, 95% confidence interval [CI] 5.40-12.46). Similarly, V-P-T use versus nonuse was associated with a higher 30-day risk of hospitalization with hyponatremia (34/20,155 [0.17%] versus 26/40,310 [0.06%]; RR 2.62, 95% CI 1.57-4.36). SIGNIFICANCE: Older adults prescribed carbamazepine and V-P-T have a higher risk of being hospitalized with hyponatremia compared to other adults with similar indicators of baseline health who were not prescribed antiepileptic drugs. Physicians should be mindful of this risk; when a patient presents to a hospital with symptomatic hyponatremia these drugs should be considered as potential causes. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  Adverse drug event; Antiepileptic drugs; Hyponatremia

Mesh:

Substances:

Year:  2016        PMID: 27896804     DOI: 10.1111/epi.13593

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Identifying Ontario geographic regions to assess adults who present to hospital with laboratory-defined conditions: a descriptive study.

Authors:  Carina Iskander; Eric McArthur; Danielle M Nash; Sonja Gandhi-Banga; Matthew A Weir; Flory Tsobo Muanda; Amit X Garg
Journal:  CMAJ Open       Date:  2019-10-22

2.  Phenytoin Toxicity Treatment with Haemodialysis in Epilepsy due to Glioblastoma Multiforme: Case Report and Review of the Literature.

Authors:  Karishma Sharma; Aditi Vakil; Ahmed Sokwala; Dilraj Sokhi
Journal:  Case Rep Neurol       Date:  2019-12-10

Review 3.  Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy.

Authors:  Enes Akyüz; Betül Köklü; Cansu Ozenen; Alina Arulsamy; Mohd Farooq Shaikh
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

4.  Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.

Authors:  Katrin Druschky; Stefan Bleich; Renate Grohmann; Rolf R Engel; Alexandra Kleimann; Susanne Stübner; Waldemar Greil; Sermin Toto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-01       Impact factor: 5.270

Review 5.  Hyponatremia in the elderly: challenges and solutions.

Authors:  Theodosios D Filippatos; Andromachi Makri; Moses S Elisaf; George Liamis
Journal:  Clin Interv Aging       Date:  2017-11-14       Impact factor: 4.458

6.  Acute hyponatremia with accompanying hyperammonemia secondary to divalproex sodium: A case report.

Authors:  Ashley J Maister; Gregory T Bogart
Journal:  Ment Health Clin       Date:  2018-06-29

7.  Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy.

Authors:  Robert T Wechsler; Rodney A Radtke; Michael Smith; David G Vossler; Laura Strom; Eugen Trinka; Hailong Cheng; Todd Grinnell; David Blum; Mariana Vieira; Joana Moreira; Francisco Rocha
Journal:  Epilepsia       Date:  2019-07-01       Impact factor: 5.864

Review 8.  Efficacy, Safety, and Drug-Drug Interactions for Insomnia Therapy in COVID-19 Patients.

Authors:  Billy Dwi Saputra; Jutti Levita; Resmi Mustarichie
Journal:  J Multidiscip Healthc       Date:  2022-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.